Early in the clinical course (i.e., DPO <5), a statistically significant higher proportion of participants who had dengue with warning signs had anti-DENV-IgM detected in their urine than participants with dengue (20.4% vs. 4.3%, WS = -0.16, CI95–0.23 to -0.05). Here, CD40LG is linked to dengue disease.